$1.90
0.3825%
Ult. Agg.: Oct 12, 7:23 PM
$1.82
0.3019.74%
Processa Pharma (PCSA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.00 | $-1.00 | $-1.30 | $-2.00 |
| Actual | $-1.19 | $-1.29 | $-0.11 | $-1.75 |
| Surprise | -19.0% | -29.0% | +91.5% | +12.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.00 | $-0.75 |
| Revenue | ||
| Consensus | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-1.19 | $-1.00 | -19.0 % |
| Q1 | May 7, 2026 | $-1.29 | $-1.00 | -29.0 % |
| Q4 | Mar 18, 2026 | $-0.11 | $-1.30 | 91.5 % |
| Q3 | Nov 6, 2025 | $-1.75 | $-2.00 | 12.5 % |